Search
for
Sort by
Research 631–660 of 1000+
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Alopecia areata after belimumab use in a patient with systemic lupus erythematosus: a paradoxical case of autoimmunity
- Alopecia Areata: Hair and Nail Findings in a Patient Undergoing Talquetamab Therapy for Multiple Myeloma
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Evaluation of Serum Vitamin-D Levels in Patients with Alopecia Areata
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- P100: Efficacy of current treatments under study in patients with alopecia areata
- Serum Level of Programmed Death Ligand1 in Alopecia Areata Patients in Relation to Disease Severity
- THE EFFECT OF AUTOLOGOUS PLATELET RICH PLASMA (PRP) ON PATIENTS WITH ALOPECIA AREATA
- Extensive alopecia areata: A multicenter review of 132 patients
- Clinical, Demographic and Laboratory Featuresof Patients with Alopecia Areata in Tokat Region
- Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- [Selective changes in lymphocytic differentiation antigens in the peripheral blood of patients with alopecia areata treated with oral zinc].
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Study on Serum Vitamin D in Alopecia Areata Patients
- Evaluation of dermatoscopic findings of alopecia areata and tinea capitis in pediatric patients
- Clinical Profile and Predictors of Relapse in Patients with Alopecia Areata: A Follow-Up Study
- Trace elements levels in serum and hair of patients with vitiligo and alopecia areata
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Effect of nutrient antioxidants on oxidative stress indicators in patients with alopecia areata
- Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Hormonal and Immunological Correlations in Alopecia Areata Patients: Focus on Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH)
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial Program